CUD

Pelago, a digital clinic partner to U.S. businesses and health plans for substance use management, announced Tuesday the addition of cannabis to its specialized substance use disorder (SUD) treatments. The new program, which will be fully implemented by Q3 2024, expands the New York-headquartered...

A new analysis of the genomes of more than 1 million people brings insights into the connections between genes and cannabis user disorder (CUD), reported Yale News.  Researchers examined a genome-wide set of genetic variants in individuals from multiple ancestry groups enrolled in...

Cannabis consumers who tend to choose high potency weed for their pleasure, are at higher risk of becoming addicted or developing marijuana-caused psychosis, a new study shows. “Overall, use of higher potency cannabis, relative to lower potency cannabis, was associated with an increased risk...